Clinical Trial Update: Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD [Phase 4]

View source ↗

Summary

A Phase 4 trial investigated the roles of Sevelamer and Fetuin-A in endothelial dysfunction associated with chronic kidney disease. The study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Endothelial Dysfunction

Drugs mentioned

• Fetuin-A (fetuin-A)
• Sevelamer (sevelamer hydrochloride)

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Vascular Diseases | Phase 4 | Status: COMPLETED